---

---

cancer   published : This week   

save search

---

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ANIX | News | $3.09 1.31% 1.29% 59K |

Health Technology

| -1.89% | O: -1.89% H: 0.0% C: 0.0%
business cancer

---

Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ONCT | News | $8.79 -1.79% -1.82% 2.8K |

Health Technology

| Email alert Add to watchlist
onct-534 first cancer treatment for study

---

Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
PVCT | News 4 | $0.19 -15.0% 60K |

Manufacturing

| Email alert Add to watchlist
rose publication tumor preclinical for

---

UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers
Published: 2024-04-17 (Crawled : 00:00) - biospace.com/
URGN | $14.32 0.56% 0.56% 320K |

Health Technology

| -1.1% | O: 1.1% H: 0.0% C: 0.0%
association for meeting benefits

---

Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
IMMP | News | $2.205 -2.43% -2.73% 270K |

Health Technology

| -5.58% | O: -6.87% H: 0.0% C: 0.0%
tacti-004 lung positive cancer cell for trial

---

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
EVAX | $4.21 2.43% 2.38% 35K |

Manufacturing

| 3.69% | O: 0.25% H: 0.0% C: 0.0%
evx-01 first vaccine cancer trial

---

Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -0.08% | O: -0.04% H: 0.28% C: -0.16%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -0.78% | O: 1.05% H: 0.0% C: 0.0%
treatment global growth market

---

Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
PPCB | $0.0014 -41.86% 4.4M |

Manufacturing

| -7.14% | O: 0.0% H: 14.29% C: -7.14%
patent cancer biopharma for grant

---

Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M |

Health Technology

| 51.52% | O: 26.26% H: 73.2% C: 18.87%
health cancer care for commercial

---

CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
CVAC | News | $2.44 -5.06% -5.33% 710K |

Health Technology

| -7.92% | O: -0.38% H: 3.41% C: 0.95%
cancer collaboration

---

BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients
Published: 2024-04-16 (Crawled : 13:00) - biospace.com/
NIPNF | $68.91 -52.94% 120 |

Technology Services

| Email alert Add to watchlist
lung cancer immunotherapy for collaboration saga response biomarkers

---

RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate
Published: 2024-04-16 (Crawled : 12:00) - prnewswire.com
GEHC | $84.98 -0.21% -0.21% 1.8M |

n/a

| -2.67% | O: -1.94% H: 0.71% C: 0.06%
breast cancer technology advanced

---

IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation Trial Results of 100% Patient and Physician Satisfaction and 96.3% Recurrence Free Rate
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
ICCM | $1.24 -3.88% -4.03% 110K |

Manufacturing

| Email alert Add to watchlist
free breast cancer medical trial results

---

UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
URGN | $14.32 0.56% 0.56% 320K |

Health Technology

| -5.1% | O: 1.46% H: 1.17% C: -1.44%
ugn-103 fda drug bladder cancer for application

---

Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
CANF | $2.02 3.06% -2.48% 10K |

Health Technology

| -6.19% | O: 4.76% H: 0.45% C: -5.91%
drug candidate liver cancer treat namodenoson advanced

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---